tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

IDT Australia Issues New Shares, Reinforces Regulatory Compliance

Story Highlights
IDT Australia Issues New Shares, Reinforces Regulatory Compliance

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from IDT Australia Limited ( (AU:IDT) ) is now available.

IDT Australia Limited has issued 348,400 Ordinary Shares without disclosure to investors under the Corporations Act, confirming compliance with relevant provisions and indicating no undisclosed ‘excluded information’. This move reflects IDT’s strategic financial maneuvers to potentially enhance its market positioning and operational capabilities, impacting stakeholders by maintaining transparency and regulatory adherence.

More about IDT Australia Limited

IDT Australia Limited (ASX: IDT) is an Australian pharmaceutical manufacturing company located in Boronia, Victoria. The company specializes in the development and production of high potency and high containment pharmaceutical products for both local and international clients. IDT’s facilities are cGMP compliant and regularly audited by the US FDA and Australian TGA, offering comprehensive services in new drug development, scale-up, and commercial active drug manufacturing, including a variety of oral and injectable finished drug dose forms.

Average Trading Volume: 215,892

Technical Sentiment Signal: Sell

Current Market Cap: A$26.86M

For a thorough assessment of IDT stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1